These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 24849483)

  • 1. Health systems implications of the 2013 WHO consolidated antiretroviral guidelines and strategies for successful implementation.
    Holmes C; Pillay Y; Mwango A; Perriens J; Ball A; Barreneche O; Wignall S; Hirnschall G; Doherty MC
    AIDS; 2014 Mar; 28 Suppl 2():S231-9. PubMed ID: 24849483
    [No Abstract]   [Full Text] [Related]  

  • 2. Developing the 2013 WHO consolidated antiretroviral guidelines.
    Easterbrook PJ; Irvine CJ; Vitoria M; Shaffer N; Muhe LM; Negussie EK; Doherty MC; Ball A; Hirnschall G
    AIDS; 2014 Mar; 28 Suppl 2():S93-100. PubMed ID: 24849484
    [No Abstract]   [Full Text] [Related]  

  • 3. Commentary: Operational Guidance in the 2013 WHO consolidated antiretroviral guidelines.
    Assefa Y; Pillay Y; Van Damme W
    AIDS; 2014 Mar; 28 Suppl 2():S171-3. PubMed ID: 24849477
    [No Abstract]   [Full Text] [Related]  

  • 4. A monitoring and evaluation gap for WHO's community health worker guidelines, Botswana.
    Watson-Grant S; Balisi R; Kaliel D; Jamu S; Thomas J
    Bull World Health Organ; 2020 May; 98(5):370-372. PubMed ID: 32514205
    [No Abstract]   [Full Text] [Related]  

  • 5. Adoption of the 2015 World Health Organization guidelines on antiretroviral therapy: Programmatic implications for India.
    Rewari BB; Agarwal R; Shastri S; Nagaraja SB; Rathore AS
    WHO South East Asia J Public Health; 2017 Apr; 6(1):90-93. PubMed ID: 28597865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adoption of national recommendations related to use of antiretroviral therapy before and shortly following the launch of the 2013 WHO consolidated guidelines.
    Nelson LJ; Beusenberg M; Habiyambere V; Shaffer N; Vitoria MA; Montero RG; Easterbrook PJ; Doherty MC
    AIDS; 2014 Mar; 28 Suppl 2():S217-24. PubMed ID: 24849481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WHO releases a 'treat-all' recommendation for HIV patients.
    Harper KN
    AIDS; 2016 Mar; 30(5):N7. PubMed ID: 26645608
    [No Abstract]   [Full Text] [Related]  

  • 8. New HIV recommendations to improve health, reduce infections and save lives.
    Cent Eur J Public Health; 2010 Jun; 18(2):115, 124. PubMed ID: 20939263
    [No Abstract]   [Full Text] [Related]  

  • 9. National adult antiretroviral therapy guidelines in South Africa: concordance with 2003 WHO guidelines?
    Lawn SD; Wood R
    AIDS; 2007 Jan; 21(1):121-2. PubMed ID: 17148984
    [No Abstract]   [Full Text] [Related]  

  • 10. New WHO HIV treatment and prevention guidelines.
    Crowley S; Rollins N; Shaffer N; Guerma T; Vitoria M; Lo YR
    Lancet; 2010 Mar; 375(9718):874-5. PubMed ID: 19954834
    [No Abstract]   [Full Text] [Related]  

  • 11. Evolution of HIV treatment guidelines in high- and low-income countries: converging recommendations.
    Richardson ET; Grant PM; Zolopa AR
    Antiviral Res; 2014 Mar; 103():88-93. PubMed ID: 24374148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015.
    Churchill D; Waters L; Ahmed N; Angus B; Boffito M; Bower M; Dunn D; Edwards S; Emerson C; Fidler S; Fisher M; Horne R; Khoo S; Leen C; Mackie N; Marshall N; Monteiro F; Nelson M; Orkin C; Palfreeman A; Pett S; Phillips A; Post F; Pozniak A; Reeves I; Sabin C; Trevelion R; Walsh J; Wilkins E; Williams I; Winston A
    HIV Med; 2016 Aug; 17 Suppl 4():s2-s104. PubMed ID: 27568911
    [No Abstract]   [Full Text] [Related]  

  • 13. How many people living with HIV will be additionally eligible for antiretroviral treatment in Karnataka State, India as per the World Health Organization 2013 guidelines?
    Dodderi SK; Kumar AM; Naik BR; Kanchar A; B B R; Harries AD
    PLoS One; 2014; 9(9):e107136. PubMed ID: 25192338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desperate times call for desperate measures: Adapting antiretroviral service delivery in the context of the COVID-19 pandemi.
    Mukumbang FC; Kriel E; Van Wyk B; Kruger JA
    S Afr Med J; 2020 Jun; 110(8):711-712. PubMed ID: 32880290
    [No Abstract]   [Full Text] [Related]  

  • 15. Comment on: antiretroviral treatment French guidelines 2013: economics influencing science.
    Morlat P; Hoen B;
    J Antimicrob Chemother; 2014 Oct; 69(10):2881-2. PubMed ID: 24879664
    [No Abstract]   [Full Text] [Related]  

  • 16. Using modeling to inform international guidelines for antiretroviral treatment.
    Hallett TB; Menzies NA; Revill P; Keebler D; Bórquez A; McRobie E; Eaton JW
    AIDS; 2014 Jan; 28 Suppl 1():S1-4. PubMed ID: 24468942
    [No Abstract]   [Full Text] [Related]  

  • 17. HIV/AIDS: the private sector is vital.
    England R
    Lancet; 2004 Sep 18-24; 364(9439):1033-4. PubMed ID: 15380956
    [No Abstract]   [Full Text] [Related]  

  • 18. The Benefits of Immediate ART.
    Zhao Y; McGoogan JM; Wu Z
    J Int Assoc Provid AIDS Care; 2019; 18():2325958219831714. PubMed ID: 30832530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementing early-warning indicators of HIV drug resistance in the Caribbean.
    Jack N; Ravasi G; Schrooten W; Sutherland D; Ghidinelli M; Del Riego A
    Clin Infect Dis; 2012 May; 54 Suppl 4():S290-3. PubMed ID: 22544189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From policy to practice: exploring the implementation of antiretroviral therapy access and retention policies between 2013 and 2016 in six sub-Saharan African countries.
    Ambia J; Renju J; Wringe A; Todd J; Geubbels E; Nakiyingi-Miiro J; Urassa M; Lutalo T; Crampin AC; Kwaro D; Kyobutungi C; Chimbindi N; Gomez-Olive FX; Tlhajoane M; Njamwea B; Zaba B; Mee P
    BMC Health Serv Res; 2017 Nov; 17(1):758. PubMed ID: 29162065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.